Predicting the Future Burden of Diabetes in Alberta from 2008 to 2035

[1]  Jeffrey A. Johnson,et al.  Alberta Diabetes Atlas 2011 , 2011 .

[2]  L. Potvin,et al.  Trends in leisure-, transport-, and work-related physical activity in Canada 1994-2005. , 2010, Preventive medicine.

[3]  T. Craven,et al.  Erratum: Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial (The Lancet (2010) 376 (419-430)) , 2010 .

[4]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[5]  Walter T Ambrosius,et al.  Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.

[6]  K. Narayan,et al.  The Global Burden of Diabetes , 2010 .

[7]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[8]  B. Hemmelgarn,et al.  Increasing incidence and prevalence of diabetes among the Status Aboriginal population in urban and rural Alberta, 1995-2006. , 2009, Canadian journal of public health = Revue canadienne de sante publique.

[9]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[10]  J. Nunnelee.  Review of an article: The ADVANCE Collaborative Group. (2008). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. NEJM 2008;358:2560-2572. , 2008 .

[11]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[12]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[13]  L. Lipscombe.  The growing prevalence of diabetes in Ontario: are we prepared? , 2007, Healthcare quarterly.

[14]  Janet E Hux,et al.  Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study , 2007, The Lancet.

[15]  R. Koopman,et al.  Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way , 2006, Diabetologia.

[16]  James P. Boyle,et al.  Impact of Recent Increase in Incidence on Future Diabetes Burden , 2006, Diabetes Care.

[17]  M. Shields,et al.  Trends in adult obesity. , 2006, Health reports.

[18]  M. Shields.  Overweight and obesity among children and youth. , 2006, Health reports.

[19]  G. Chodick,et al.  The direct medical cost of diabetes in Israel , 2005, The European Journal of Health Economics.

[20]  R. Holman,et al.  A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.

[21]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[22]  Ian Janssen,et al.  The economic costs associated with physical inactivity and obesity in Canada: an update. , 2004, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[23]  W. Herman,et al.  The CORE Diabetes Model , 2004, Current medical research and opinion.

[24]  Volker Foos,et al.  The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making , 2004, Current medical research and opinion.

[25]  James P. Boyle,et al.  A Dynamic Markov Model for Forecasting Diabetes Prevalence in the United States through 2050 , 2003, Health care management science.

[26]  L. Gaal,et al.  Assessing the impact of complications on the costs of Type II diabetes , 2002, Diabetologia.

[27]  Janet E Hux,et al.  Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. , 2002, Diabetes care.

[28]  L S Geiss,et al.  Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.

[29]  M. Engelgau,et al.  Diabetes trends in the U.S.: 1990-1998. , 2000, Diabetes care.

[30]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[31]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[32]  A. Wajda,et al.  Incidence and Prevalence of Diabetes in Manitoba, 1986–1991 , 1996, Diabetes Care.

[33]  D N Mendelson,et al.  Health care expenditures for people with diabetes mellitus, 1992. , 1994, The Journal of clinical endocrinology and metabolism.

[34]  J. Johnson,et al.  Chapter 1 Background and Methods , 2009 .

[35]  H. Morrison,et al.  The burden of adult obesity in Canada. , 2007, Chronic diseases in Canada.

[36]  R. Zeckhauser,et al.  A primer for policy analysis , 1978 .